Skip to content

Blog

Select Health Area/Condition/Disease
Does NAD+ Decline with Age? Yes, But Blood NAD+ and Tissue NAD+ Are Not the Same

Does NAD+ Decline with Age? Yes, But Blood NAD+ and Tissue NAD+ Are Not the Same

Does NAD+ Decline with Age? Yes, But Blood NAD+ and Tissue NAD+ Are Not the Same
Aging & Longevity

Does NAD+ Decline with Age? Yes, But Blood NAD+ and Tissue NAD+ Are Not the Same

A newly published study reports that whole blood NAD+ does not decline with age, failing to account for well-documented tissue-specific declines. Human data from brain, muscle, skin, and liver cont...

Read more
Inside the NAD for Health Conference in Copenhagen: Key Takeaways from the World's Leading NAD+ Researchers
In The News

Inside the NAD for Health Conference in Copenhagen: Key Takeaways from the World's Leading NAD+ Researchers

The NAD for Health conference, top researchers spent three days doing what the NAD+ field needed: having a robust, unfiltered conversation about the science. Here is what they found–promising early...

Read more
NR vs. NMN: What the Latest Human Research Actually Shows
In The News

NR vs. NMN: What the Latest Human Research Actually Shows

Two newly published clinical studies tested NR and NMN head-to-head in humans for the first time. Explore what the latest clinical data reveals about which NAD+ precursor is more effective at incre...

Read more
Nicotinamide Riboside Chloride Now Has a USP Monograph—Here’s What That Means
In The News

Nicotinamide Riboside Chloride Now Has a USP Monograph—Here’s What That Means

The United States Pharmacopeia (USP) has published a compendial standard for nicotinamide riboside chloride (NRCl), making it one of the only NAD+ precursors to meet pharmacopeial quality benchmark...

Read more
What Is a Patent? Types, Uses, and Why They Matter for NAD+
In The News

What Is a Patent? Types, Uses, and Why They Matter for NAD+

Patents are the foundation of innovation, but understanding what they are and how they work is more nuanced than it may seem. This educational guide breaks down the types of patents, what each prot...

Read more
NAD+ and Cancer: Current Research on Supplementation Safety and Risk
Cancer

NAD+ and Cancer: Current Research on Supplementation Safety and Risk

As NAD+ supplementation grows in popularity, questions about cancer risk have emerged. This article breaks down the research, highlights misleading media claims, and delves into the nuanced science...

Read more
FDA Classifies NAD+ Injection Recalls: Understanding the Safety Risks and What You Need to Know About Endotoxins and Quality
In The News

FDA Classifies NAD+ Injection Recalls: Understanding the Safety Risks and What You Need to Know About Endotoxins and Quality

The U.S FDA has classified two recalls of NAD+ injections from GenoGenix, LLC, with the latest Class I recall linked to dangerous endotoxin contamination. Find out which products are affected, the ...

Read more
Woman holding glass of water and capsules symbolizing oral NAD+ supplement intake.
In The News

No Evidence Shows That Oral NAD+ Supplementation Increases NAD+ Levels in Humans

Oral NAD+ supplements have not been shown to increase NAD+ levels in humans, a conclusion recently supported by the National Advertising Division (NAD). Learn why the science shows oral NAD+ is ine...

Read more
Magnifying glass over supplement capsules depicting FDA review of NMN quality and safety.
In The News

FDA Reverses NMN Decision: Risks, Quality Concerns, and Alternative Options

The U.S. FDA reversed its previous ban on NMN supplements, yet low-quality products and patent challenges pose risks. Explore safe, more effective NAD+ precursors backed by science.

Read more
Microscope in laboratory setting representing testing and quality control of NAD+, NR, and NMN supplements.
In The News

NR, NMN, & NAD+ Supplements: What Testing Reveals About Quality

Despite the booming market, most NAD+ supplements fail testing, with many NR, NMN, and NAD+ products underdosed or mislabeled. Protect your health and wallet by choosing supplements with transparen...

Read more